Pay in 4 interest-free payments of $29.25 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Recombinant EPO has been approved for the treatment of anemia associated with chronic renal failure as well as for anemia of AZT treated AIDS patients
therefore preventing successful reverse transcription and transport to the nucleus of the viral genome
Extra Notes: ICC staining Phospho-AMPK alpha 2(S345) in 293 cells (green)
an AF4/ lymphoid nuclear protein related to AF4/Fragile X E mental retardation syndrome domain
Extra Notes: Western Blot (WB) analysis of KLF13 (Acetyl-K166) polyclonal antibodyat 1:500 dilution
Recombinant Human CD28/TP44 Protein (mFc Tag) - PKSH033788 Size:50μg Recombinant EPO has been approvedRecombinant Human CD28 TP44 Protein (mFc Tag) Sizes: 10g, 50g Catalogue Numbers: PKSH033788 10, PKSH033788 50 Citations, Manuals and MSDS Available upon request. Abbreviation: CD28; TP44 Target Symptom: CD28; CD28 antigen; CD28 molecule; T cell specific surface glycoprotein CD28; Tp44; TP44 Research Area: immunology; Stem cells Target Species: Human Expression Host: HEK293 Cells Fusion Tag: C mFc UNIProt ID: P10747 Accession: P10747 Background: T cell